Buscar
Labcorp Holdings Inc
LHAñadir a la lista de seguimiento
321.480USD
-3.380-1.04%
Horarios del mercado 09/09, 09:41（ET）
26.01BCap. mercado
28.29P/E TTM
Más Datos de Labcorp Holdings Inc Compañía
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Perfil de Labcorp Holdings Inc
Símbolo de cotizaciónLH
Nombre de la empresaLabcorp Holdings Inc
Fecha de salida a bolsaApr 24, 1991
Director ejecutivoSchechter (Adam H)
Número de empleados70000
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 24
Dirección358 S Main St
CiudadBURLINGTON
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal27215
Teléfono13362291127
Sitio Webhttps://www.labcorp.com/
Símbolo de cotizaciónLH
Fecha de salida a bolsaApr 24, 1991
Director ejecutivoSchechter (Adam H)
Ejecutivos de Labcorp Holdings Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
102.56K
-4.55%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
13.74K
--
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
6.96K
-13.29%
Ms. Kerrii B. Anderson
Ms. Kerrii B. Anderson
Independent Director
Independent Director
6.85K
-43.79%
Mr. Bryan T. Vaughn
Mr. Bryan T. Vaughn
Executive Vice President - Diagnostics
Executive Vice President - Diagnostics
6.75K
--
Ms. Sandra Dillard van Der Vaart
Ms. Sandra Dillard van Der Vaart
Executive Vice President, Chief Legal Officer, and Corporate Secretary
Executive Vice President, Chief Legal Officer, and Corporate Secretary
5.82K
+62.94%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
102.56K
-4.55%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
Executive Vice President, President, Biopharma Laboratory Services and Chief Medical and Scientific Officer
36.49K
+17.78%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+8.75%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
15.04K
+56.95%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
13.78K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
13.74K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Labcorp Holdings Inc?
Los cinco principales accionistas de Labcorp Holdings Inc son: Mr. Adam H. Schechter
¿Cuántas instituciones poseen acciones de Labcorp Holdings Inc (LH)?
A fecha de 2026Q1, 1855 instituciones poseen acciones de Labcorp Holdings Inc, con un valor de mercado combinado de aproximadamente 88.74M, lo que representa el 108.22% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 5570263.00.